Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
Washington University School of Medicine
Washington University School of Medicine
OHSU Knight Cancer Institute
Children's Oncology Group
National Cancer Institute (NCI)